Schedule 13G ownership disclosure

Pacific Biosciences of California Inc

Common Stock, par value $0.001 · CUSIP: 69404D108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Madrone Capital Partners, LLC

    Shares: 4,976,089.00 · Class: 1.7%

  • Madrone Opportunity Fund, L.P.

    Shares: 4,976,089.00 · Class: 1.7%

  • Shimoda Holdings, LLC

    Shares: 3,500,000.00 · Class: 1.2%

  • Gregory Boyd Penner

    Shares: 8,476,089.00 · Class: 2.8%

  • Jameson J. McJunkin

    Shares: 4,976,089.00 · Class: 1.7%

  • Thomas Patterson

    Shares: 4,976,089.00 · Class: 1.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001789147-25-000008
Form type
SCHEDULE 13G/A
Filer
MADRONE CAPITAL PARTNERS, LLC
CIK
CIK 1789147
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub